HuGE Literature Finder
Records
1
-
6
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis. Biochemistry and biophysics reports 2022 9 32 101337. Afief Arief Rahman, Irham Lalu Muhammad, Adikusuma Wirawan, Perwitasari Dyah Aryani, Brahmadhi Ageng, Cheung Roc |
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Journal of personalized medicine 2021 Oct 11 (10): . Zarzuelo-Romero María José, Pérez-Ramírez Cristina, Cura Yasmín, Carrasco-Campos María Isabel, Marangoni-Iglecias Luciana María, Ramírez-Tortosa María Carmen, Jiménez-Morales Alber |
DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis. PloS one 2021 4 16 (4): e0248905. Taman Hagar, Fenton Christopher G, Anderssen Endre, Florholmen Jon, Paulssen Ruth |
Mitonuclear interactions influence multiple sclerosis risk. Gene 2020 Jul 144962. Kozin Maxim, Kulakova Olga, Kiselev Ivan, Baulina Natalia, Boyko Alexey, Favorova Ol |
Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population. Neurological research 2017 Jan 1-6. Abdollah Zadeh Rasoul, Jalilian Nazanin, Sahraian Mohammad Ali, Kasraian Zeinab, Noori-Daloii Mohammad Re |
CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Human immunology 2010 Nov 71 (11): 1141-6. Liu Yun, Liang Wei-Bo, Gao Lin-Bo, Pan Xin-Min, Chen Tian-Yi, Wang Yan-Yun, Xue Hui, Zhang Lu-shun, Zhang L |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: